Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2022JAMA Network OpenOpen Access

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

View Full Paper
Ask AI
Bookmark
Share

Authors

SSStephanie J. SchragJVJennifer R. VeraniBDBrian E. Dixon

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schrag et al. (2022) studied this question.

synapsesocial.com/papers/69dabecd7a67537a8ba3c4eahttps://doi.org/10.1001/jamanetworkopen.2022.33273
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications2022 · 283 citations
  2. 2Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 20222022 · 480 citations
  3. 3Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies2015 · 4,541 citations
  4. 4Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression2022 · 1,236 citations